MB Therapeutics Expands its Team with the Arrival of Léna Lemierre, an Expert in Pharmaceutical 3D Printing
Continuing its goal of enhancing pharmaceutical development capabilities associated with 3D printing technology, MB Therapeutics is delighted to announce the addition of Léna Lemierre to its team. With a strong track record of innovation and experience in pharmaceutical 3D printing, Léna will accelerate the development of personalized medicine.
A vision for the future
“Joining MB Therapeutics is an exciting challenge, placing the patient at the center of healthcare offerings, an essential innovation for the production of tomorrow’s medicines.” Léna Lemierre
With Léna Lemierre on board, MB Therapeutics reaffirms its commitment to providing personalized medicine through 3D printing. Her passion for innovation and determination to shape the medicine of the future align perfectly with the company’s goals. Léna’s integration into the team reinforces MB Therapeutics’ ambition to be a leading player in pharmaceutical 3D printing.
Expertise in Pharmaceutical 3D Printing
Léna Lemierre brings over three years of experience in industrial pharmaceutical 3D printing to MB Therapeutics. Throughout her career, she has developed pharmaceutical cartridges for pediatric use. Her practical experience in designing and optimizing pharmaceutical 3D printing technologies has resulted in innovative solutions that align perfectly with MB Therapeutics’ commitment to pushing the boundaries of healthcare.
Excellence in Engineering from IMT Albi
Léna holds an engineering degree from IMT Albi, a prestigious institution known for producing top talents in engineering and technology. Her academic background, combined with her experience in the healthcare sector, gives her a unique profile.
Conclusion
The recruitment of Léna Lemierre as an R&D engineer confirms MB Therapeutics’ dedication to innovation and excellence in pharmaceutical 3D printing. With her extensive experience, academic credentials, and forward-looking vision, Léna is best positioned to contribute to the company’s mission: Revolutionizing personalized medicine through cutting-edge technology.
For more information on Léna’s contributions and the latest developments in pharmaceutical 3D printing, stay tuned for the latest news from MB Therapeutics.
